Pipeline Watch: LentiGlobin, BMS-986205 Phase III Studies Initiated
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.